Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urbitter is a line of herbal dietary supplements developed by Dr. Pandalis, a German company specializing in natural medicines and European ethnomedicine. The product line, which includes teas and capsules, is formulated with a variety of bitter herbs intended to support digestive health and metabolic function. Key ingredients typically include *Cistus incanus* (Cystus), dandelion (*Taraxacum officinale*), artichoke (*Cynara scolymus*), and gentian (*Gentiana lutea*). These herbs are traditionally used for their choleretic and digestive-stimulating properties, helping to compensate for the lack of bitter substances in modern diets. The products are marketed as organic (Bio) and are intended to stimulate the body's natural digestive processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Urbitter.